New anticoagulants in patients with non-valvular atrial fibrillation

被引:0
作者
Zellerhoff, S. [1 ]
Lewalter, T. [2 ,4 ]
Eckardt, L. [1 ]
Treszl, A. [3 ,4 ]
Wegscheider, K. [3 ,4 ]
Breithardt, G. [1 ,4 ]
机构
[1] Univ Klinikum Munster, Dept Kardiol & Angiol, Abt Rhythmol, D-48149 Munster, Germany
[2] Isar Herzzentrum, Munich, Germany
[3] Univ Klinikum Hamburg Eppendorf, Dept Med Biometrie & Epidemiol, Hamburg, Germany
[4] Univ Munster, Kompetenznetz Vorhofflimmern, D-4400 Munster, Germany
关键词
Atrial fibrillation; antithrombotic therapy; stroke; DIRECT THROMBIN INHIBITOR; LY RANDOMIZED EVALUATION; ACUTE ISCHEMIC-STROKE; ORAL ANTICOAGULATION; RISK-FACTORS; DABIGATRAN; WARFARIN; RIVAROXABAN; PREVENTION; THERAPY;
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Atrial fibrillation is the most frequent sustained cardiac arrhythmia and a common reason for therapeutic anticoagulation in patients exhibiting additional risk factors for thromboembolic events. For several decades, the mainstay therapy have been oral vitamin K antagonists despite their shortcomings in daily practice including difficult dosage due to food and drug interactions and the need for regular monitoring of the intensity of anticoagulation. Newly developed anticoagulants include oral, direct thrombin antagonists (dabigatran) and factor Xa antagonists (rivar-oxaban, apixaban). Apart from a lesser potential for interactions and thereby greater ease of use, these substances have shown a favorable risk/benefit profile in large randomized clinical trials, preventing stroke and other systemic thromboembolic events at least as effective as warfarin while reducing hemorrhagic stroke and intracranial bleeding compared to warfarin. These findings were also consistent in subgroup analyses of high-risk patients in secondary stroke prophylaxis.
引用
收藏
页码:813 / 820
页数:8
相关论文
共 48 条
[1]  
[Anonymous], BR MED J
[2]   Clinical laboratory measurement of direct factor Xa inhibitors: Anti-Xa assay is preferable to prothrombin time assay [J].
Barrett, Yu Chen ;
Wang, Zhaoqing ;
Frost, Charles ;
Shenker, Andrew .
THROMBOSIS AND HAEMOSTASIS, 2010, 104 (06) :1263-1271
[3]   The metabolism and disposition of the oral direct thrombin inhibitor, dabigatran, in humans [J].
Blech, Stefan ;
Ebner, Thomas ;
Ludwig-Schwellinger, Eva ;
Stangier, Joachim ;
Roth, Willy .
DRUG METABOLISM AND DISPOSITION, 2008, 36 (02) :386-399
[4]  
Camm AJ, 2010, EUROPACE, V12, P1360, DOI [10.1093/europace/euq350, 10.1093/eurheartj/ehq278]
[5]  
Clinicaltrials.gov, 2012, DRUG INT STUD DAB ET
[6]   Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial [J].
Connolly, S. ;
Pogue, J. ;
Hart, R. ;
Pfeffer, M. ;
Hohnloser, S. ;
Chrolavicius, S. ;
Yusuf, S. .
LANCET, 2006, 367 (9526) :1903-1912
[7]   Effect of Clopidogrel Added to Aspirin in Patients with Atrial Fibrillation [J].
Connolly, S. J. ;
Yusuf, S. ;
Camm, J. ;
Chrolavicius, S. ;
Commerford, P. ;
Flather, M. ;
Hart, R. G. ;
Hohnloser, S. H. ;
Joyner, C. ;
Pfeffer, M. ;
Gaudin, C. ;
Blumenthal, M. ;
Marchese, C. ;
Pogue, J. ;
Hart, R. ;
Hohnloser, S. ;
Anand, I. ;
Arthur, H. ;
Avezum, A. ;
Budaj, A. ;
Ceremuzynski, L. ;
De Caterina, R. ;
Diaz, R. ;
Dorian, P. ;
Flaker, G. ;
Fox, K. A. A. ;
Franzosi, M. G. ;
Goldhaber, S. ;
Golitsyn, S. ;
Granger, C. ;
Halon, D. ;
Hermosillo, A. ;
Hunt, D. ;
Jansky, P. ;
Karatzas, N. ;
Keltai, M. ;
Kozan, O. ;
Lanas, F. ;
Lau, P. ;
Le Heuzey, J. Y. ;
Lewis, B. S. ;
Morais, J. ;
Morillo, C. ;
Paolasso, E. ;
Peters, R. J. ;
Pfisterer, M. ;
Piegas, L. ;
Pipilis, A. ;
Sitkei, E. ;
Swedberg, K. .
NEW ENGLAND JOURNAL OF MEDICINE, 2009, 360 (20) :2066-2078
[8]   Newly Identified Events in the RE-LY Trial [J].
Connolly, Stuart J. ;
Ezekowitz, Michael D. ;
Yusuf, Salim ;
Reilly, Paul A. ;
Wallentin, Lars .
NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (19) :1875-1876
[9]   Dabigatran versus Warfarin in Patients with Atrial Fibrillation. [J].
Connolly, Stuart J. ;
Ezekowitz, Michael D. ;
Yusuf, Salim ;
Eikelboom, John ;
Oldgren, Jonas ;
Parekh, Amit ;
Pogue, Janice ;
Reilly, Paul A. ;
Themeles, Ellison ;
Varrone, Jeanne ;
Wang, Susan ;
Alings, Marco ;
Xavier, Denis ;
Zhu, Jun ;
Diaz, Rafael ;
Lewis, Basil S. ;
Darius, Harald ;
Diener, Hans-Christoph ;
Joyner, Campbell D. ;
Wallentin, Lars .
NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (12) :1139-1151
[10]   The antih ae morrhagic vitamin of the chick - Occurrence and chemical nature [J].
Dam, H .
NATURE, 1935, 135 :652-653